Journals / Tüberküloz ve Toraks / 2021 / Cilt: 69 - Sayı: 2

Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study

Hastaneye yatan COVID-19 hastalarında mortalite belirteçlerinin değerlendirilmesi: Retrospektif kohort çalışması

Pages
196–206
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The relationship between clinical and laboratory markers and mortality is very important for the correct orientation of healthcare services and the correct determination of treatment strategy during the COVID-19 pandemic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Evaluation of parameters that will predict prognosis in COVID19 disease ensures correct determination of treatment strategy.
📊
Key Findings & Data:Materials and Methods: Patients hospitalized with the diagnosis of COVID-19 in September 2020 were included in the study.
💡
Conclusion & Impact:Conclusion: The relationship between clinical and laboratory markers and mortality is very important for the correct orientation of healthcare services and the correct determination of treatment strategy during the COVID-19 pandemic.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Evaluation of parameters that will predict prognosis in COVID19 disease ensures correct determination of treatment strategy. In this study, it was aimed to determine the clinical, radiological and laboratory parameters affecting mortality and to evaluate the risk factors. Materials and Methods: Patients hospitalized with the diagnosis of COVID-19 in September 2020 were included in the study. Clinical features, laboratory parameters, and radiological findings at admission were recorded. The relationship of these parameters with 30-day mortality was evaluated. Statistical analysis was performed with SPSS for Windows 16.0 Package Program. Results: Three hundred and sixty patients (female/male, n= 228/132) hospitalized in the specified period were included in the study. 30-day mortality rate was 14.4% in all patients. In multiple logistic regression analysis, age, presence of heart failure, admission oxygen saturation, body temperature higher than 38.2 and high ferritin levels were evaluated as independent risk factors for 30-day mortality. Conclusion: The relationship between clinical and laboratory markers and mortality is very important for the correct orientation of healthcare services and the correct determination of treatment strategy during the COVID-19 pandemic.

Özet

Giriş: COVID-19 hastalığında prognoz tahmin ettirecek parametrelerin saptanması tedavi stratejisinin doğru belirlenmesini sağlamaktadır. Bu çalışmada mortaliteye etki eden klinik, radyolojik ve laboratuvar parametrelerinin belirlenmesi, risk faktörlerinin değerlendirilmesini amaçlanmıştır. Materyal ve Metod: Eylül 2020’de COVID-19 tanısı ile hastaneye yatırılan hastalar çalışmaya dahil edildi. Başvuru sırasındaki klinik özellikleri, laboratuvar parametreleri, radyolojik bulguları kaydedildi. Bu parametrelerin 30 günlük mortalite ile ilişkisi değerlendirildi. İstatistiksel analizler SPSS-for-Windows 16.0 Paket Programı ile yapıldı. Bulgular: Belirtilen sürede hastaneye yatan 360 hasta (228/132, K/E) çalışmaya alındı. Tüm hastalarda 30 günlük mortalite oranı 14,4% saptandı. Çoklu Lojistik regresyon analizinde yaş, kalp yetmezliği varlığı, başvuru oksijen satürasyonu, vücut sıcaklığının 38,2’den yüksek olması ve yüksek ferritin düzeyleri 30 günlük mortalite için bağımsız risk faktörleri olarak değerlendirildi. Sonuç: Klinik ve laboratuvar belirteçler ile mortalite arasındaki ilişki, COVID-19 salgını sırasında sağlık hizmetlerinin doğru yönlendirilmesi ve tedavi stratejisinin doğru belirlenmesi açısından çok önemlidir.

🔖

Cite This Article

ŞENER, A., ŞENER, M. U., ÖZTÜRK, A., YILDIZ, M., KAVURGACI, S., ERGÜR, F. Ö. (2022). Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study. Tüberküloz ve Toraks, Cilt: 69 - Sayı: 2, 196–206. https://ajindex.com/articles/618320

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Yadaw AS, Li YC, Bose S, Iyengar R, Bunyavanich S, Pandey G. Clinical features of COVID-19 mortality: development and validation of a clinical prediction model. Lancet Digit Health 2020;2(10):e516-e525
  2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-20
  3. Siordia JA. Epidemiology and clinical features of COVID19: a review of current literature. J Clin Virol 2020; 127: 10435
  4. Kinross P, Suetens C, Gomes Dias J, Alexakis L, Wijermans A, Colzani E, et al. Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020. Euro Surveill Mar 2020; 25(11): 2000285
  5. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J 2020; 55(5): 2000524
  6. Meng Y, Wu P, Lu W, Liu K, Ma K, Huang L, et al. (2020) Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLoS Pathog 16(4): e1008520
  7. Galloway JB, Norton S, Barker RD, Brookes A, Carey I, Clarke BD, et al. A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study. J Infect 2020; 81(2): 282-8
  8. Mudatsir M, Fajar JK, Wulandari L, Soegiarto G, Ilmawan M, Purnamasari Y, et al. Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Res 2020; 9: 1107
  9. Ferlita S, Yegiazaryan A, Noori N, Lal G, Nguyen T, To K, et al. Type 2 Diabetes Mellitus and altered immune system leading to susceptibility to pathogens, especially Mycobacterium tuberculosis. J Clin Med 2019; 8(12): 2219
  10. Lazzerini PE, Hamilton RM, Boutjdir M. Editorial: cardioimmunology: inflammation and immunity in cardiovascular disease. Front Cardiovasc Med 2019; 6: 181
  11. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019‐nCoV infected patients linked to viral loads and lung injury. Science China Life Sci 2020; 63(3): 364‐74
  12. Shang W, Dong J, Ren Y, Tian M, Li W, Hu J et al. The value of clinical parameters in predicting the severity of COVID‐19. J Med Virol 2020; 92(10): 2188-92
  13. Terpos E, Ntanasis‐Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. He